Question 1

Is Mycobutin 150Mg Hard Capsules (Rifabutin) currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Mycobutin 150Mg Hard Capsules (Rifabutin) has 2 active shortage notices across 2 countries (European Union, Ireland). Status is refreshed daily from official regulatory sources.

Question 2

Why is Mycobutin 150Mg Hard Capsules (Rifabutin) in shortage?

Accepted Answer

Regulators attribute the current Mycobutin 150Mg Hard Capsules (Rifabutin) shortages to causes not stated by the regulator, supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

Where does this Mycobutin 150Mg Hard Capsules (Rifabutin) shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
European Union	high	1	30 Jun 2026	—	EMA
Ireland	medium	1	11 May 2026	—	HPRA

Mycobutin 150Mg Hard Capsules (Rifabutin) shortage status

Where Mycobutin 150Mg Hard Capsules (Rifabutin) is in shortage

Why Mycobutin 150Mg Hard Capsules (Rifabutin) is in shortage

Frequently asked questions

Get alerted when Mycobutin 150Mg Hard Capsules (Rifabutin) status changes